Detection of Cognitive Changes in Premanifest Huntington’s disease Using the Repeatable Battery for the Assessment of Neuropsychological Status
Objective: The current study is an examination of cognitive changes in premanifest gene carriers for Huntington’s disease (preHD), individuals with manifest Huntington’s disease (HD), and…Do dreams tell the future? Dream content analysis as a predictor of cognitive deterioration in Parkinson’s Disease
Objective: Assess the predicitive value of dream content for cognitive dysfuncion progression in Parkinson's Disease (PD). Background: PD patients frequently complain of vivid dreams. Cross-sectional…Genetic and environmental prognostics of cognitive trajectories in patients with Parkinson’s disease
Objective: We aimed to investigate the progression patterns of cognitive impairment in patients with Parkinson’s disease (PD), and to identify the baseline predictors, including both…Short digitalized cognitive test help differentiating Parkinson’s disease (PD) patients with and without Mild Cognitive Impairment (MCI)
Objective: We explored the capacity of a new digitalized multi-domain cognitive battery, to differentiate PD patients with MCI from those without MCI. Background: MCI is…Cognitive function and quality of life in Parkinson’s disease: A cross-sectional study
Objective: We aimed to determine how the cognitive domains affect quality of life (QoL) in different cognitive states in PD. Background: Parkinson’s disease with mild…Free Water in Corpus Callosum is Sensitive to Parkinson’s Disease-related Cognitive Decline
Objective: The objective of this study was to determine if the novel diffusion metric, free water (FW), from two-tensor modeling could sensitively identify microstructural alterations…Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment patients with Parkinson’s disease
Objective: Due to the high prevalence of mild cognitive impairment (MCI) in Parkinson disease (PD), routine cognitive screening is important for the optimal management of…Clinical profile and cerebral metabolic characteristic of cognitive impairments in multiple system atrophy
Objective: This study aimed to characterize the cognitive profiles of multiple system atrophy (MSA) and explore the possible mechanisms involved using 18F-fluorodeoxyglucose (FDG) Positron Emission…Motor and non-motor symptoms in Huntington’s disease patients in the Tomsk region, Russia
Objective: The aim is to evaluate features of NMS in PwHD of Tomsk region. Background: Patients with Huntington's disease(PwHD) can complain of other non-motor symptoms(NMS)…Understanding characteristics, healthcare resource use and costs of patients with Parkinson’s disease prior to and after diagnosis of cognitive impairment
Objective: The primary goal of this retrospective cohort study was to understand characteristics, healthcare resource use (HCRU) and costs of patients with PD before and…
- « Previous Page
- 1
- …
- 53
- 54
- 55
- 56
- 57
- …
- 117
- Next Page »